Clinical Trials Browser

Crohn Disease × Adalimumab × Clear all

NCT04655807 2025-04-27

DUET

Phase 2 Withdrawn

Crohn Disease

NCT04646187 2025-01-06

FREE

Phase 4 Enrolling by invitation

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT02499783 2019-01-04

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Phase 3 Completed

205 enrolled 39 charts

Crohn Disease